FENC
FENNEC PHARMACEUTICALS INC. · Healthcare · Market cap $434.5M
Insiders sold $1.3M net in the last 90 days ·3 sellers, 0 buyers· 4 of 5 sales under Rule 10b5-1 plans· latest Form 4 filed Sep 1, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$12.5M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Latest filing
Sep 1, 2026
Sayad Pierre Sargis
FENNEC PHARMACEUTICALS INC. (FENC) has 69 SEC Form 4 filings (101 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Sep 1, 2026.
Inside the rolling window, 5 insiders at FENNEC PHARMACEUTICALS INC. reported no open-market purchases and 23 open-market sales totaling $12.5M. The most active filer is Insider Raykov Rosty with 12 filings. Insiders have net sold $1.6M over the trailing 6 months. The most recent open-market filing is a sale of 12,000 shares by Chief Medical Officer Sayad Pierre Sargis, dated Aug 31, 2026, worth $146K.
- Industry:Biotechnology
- CEO:Jeffrey S. Hackman
- Employees:35
- HQ:Research Triangle Park, NC, US
- IPO:2017-09-15
| Source | |||||||
|---|---|---|---|---|---|---|---|
Sayad Pierre SargisFirst filing | Chief Medical Officer | Sale | 12,000 | $146K | Sep 1 | +3.0% | SEC ↗ |
| Former Director | Sale | 10,000 | $121K | Sep 1 | +3.0% | SEC ↗ | |
Andrade RobertFirst filing | CHIEF FINANCIAL OFFICER | Sale | 75,000 | $884K | Aug 28 | +1.0% | SEC ↗ |
| Former Director | Sale | 10,000 | $96K | Aug 4 | +22.6% | SEC ↗ | |
| Former Director | Sale | 9,599 | $100K | Jul 2 | +15.8% | SEC ↗ | |
| Director | Sale | 9,747 | $94K | Jun 2 | +24.1% | SEC ↗ | |
RALLIS CHRIS AFirst in 7 months | Director | Sale | 8,346 | $59K | May 12 | +76.2% | SEC ↗ |
| Director | Sale | 10,781 | $70K | May 1 | +89.4% | SEC ↗ | |
| Director | Sale | 10,946 | $69K | Apr 2 | +93.0% | SEC ↗ | |
| Director | Sale | 10,079 | $84K | Mar 3 | +54.9% | SEC ↗ | |
| Director | Sale | 10,349 | $80K | Feb 2 | — | SEC ↗ | |
| Director | Sale | 10,312 | $78K | Jan 5 | — | SEC ↗ | |
| 10% Owner | Sale | 1,000,000 | $7.5M | Dec 29 | — | SEC ↗ | |
| Director | Sale | 10,000 | $75K | Dec 5 | — | SEC ↗ | |
| 10% Owner | Sale | 19,341 | $170K | Nov 20 | — | SEC ↗ | |
| 10% Owner | Sale | 160,100 | $1.3M | Nov 17 | — | SEC ↗ | |
| 10% Owner | Sale | 85,918 | $755K | Nov 17 | — | SEC ↗ | |
| Director | Sale | 10,000 | $81K | Nov 6 | — | SEC ↗ | |
RALLIS CHRIS AFirst filing | Director | Sale | 1,775 | $16K | Oct 14 | — | SEC ↗ |
Southpoint Capital Advisors LPFirst filing | 10% Owner | Sale | 26,900 | $258K | Oct 9 | — | SEC ↗ |
Southpoint Capital Advisors LPFirst filing | 10% Owner | Sale | 19,605 | $186K | Oct 9 | — | SEC ↗ |
Southpoint Capital Advisors LPFirst filing | 10% Owner | Sale | 20,609 | $193K | Oct 9 | — | SEC ↗ |
Raykov RostyFirst filing | Director | Sale | 10,000 | $98K | Oct 6 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does FENC have?
FENNEC PHARMACEUTICALS INC. (FENC) has 69 SEC Form 4 filings (101 transaction rows) in the rolling 365-day window, disclosed by 5 distinct insiders. Most recent filing: Sep 1, 2026.
When was the most recent SEC Form 4 filing for FENC?
The most recent Form 4 filing for FENC on Tracefour is dated Sep 1, 2026.
Who is the most active insider at FENC?
The most active SEC Form 4 filer at FENC in the rolling window is Insider Raykov Rosty, with 12 filings.
What is the net insider flow at FENC over the last 6 months?
Over the trailing 180 days, insiders at FENC have net sold $1.6M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at FENC in the current window?
Inside the rolling window, insiders at FENC bought $0 and sold $12.5M based on SEC Form 4 filings.
Can I get alerts for FENC insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at FENNEC PHARMACEUTICALS INC. (FENC). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
FENNEC PHARMACEUTICALS INC. is in the Healthcare sector.